Abich Financial Wealth Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
DG
NI
Abich Financial Wealth Management's HCAT Position: Q3 2024 in Review
Abich Financial Wealth Management sold out of Health Catalyst (HCAT) in Q3 2024, closing a stake of 143 shares — an estimated $914 sold.
Abich Financial Wealth Management first reported a position in HCAT in Q2 2024 and held it in 1 quarter. The position peaked at $914 in Q2 2024. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2024.
- Abich Financial Wealth Management reported no remaining Health Catalyst position as of Q3 2024 after selling out during the quarter.
- Abich Financial Wealth Management sold 143 Health Catalyst shares in Q3 2024, an estimated $914.
- Abich Financial Wealth Management first reported a position in Health Catalyst in Q2 2024 and held it in 1 quarter.
- Abich Financial Wealth Management's Health Catalyst position peaked at $914 in Q2 2024.
- 159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2024.
Based on Abich Financial Wealth Management's 13F filing for Q3 2024, filed 25 Oct 2024.